Second Phase II trial of ZYN001 in patients with fibromyalgia and peripheral neuropathic pain.
Phase of Trial: Phase II
Latest Information Update: 31 Mar 2017
At a glance
- Drugs ZYN 001 (Primary)
- Indications Fibromyalgia; Neuropathic pain
- Focus Therapeutic Use
- 31 Mar 2017 New trial record
- 27 Mar 2017 This trial is expected to begin in the second half of 2017, according to a Zynerba Pharmaceuticals media release.